SecBot SecBot
144 ·Filed Aug 12, 2026

TWST

Twist Bioscience Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001959173-26-005946
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine tax-withholding sale by a director with no discretionary signal. Monitor for any larger discretionary insider sales in the coming weeks, but this filing alone does not warrant a trading response.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$125.29
T+0 close · Aug 12, 2026 · via day close
Latest settled
−3.59%
T+60 · $120.79
Vs SPY
+1.88%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 13 $125.29entry
  2. T+1 · 3mo ago −5.36%α −5.17% · $118.57
  3. T+5 · 3mo ago +8.73%α +10.70% · $136.23
  4. T+20 · 2mo ago +1.54%α +3.29% · $127.22
  5. T+60 · 11d ago −3.59%α +1.88% · $120.79
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Katryn Blake filed a Form 144 to sell 2,240 shares of Twist Bioscience common stock, valued at approximately $275,250. The sale is a tax-withholding transaction tied to the settlement of a vested equity award, not a discretionary portfolio liquidation. Given the small proportional size relative to the company's $8.2B market cap and the tax-motivated nature, this filing carries minimal standalone signal for the stock.

Key Facts

  • Director Katryn Blake filed Form 144 to sell 2,240 shares of Twist Bioscience common stock.
  • The proposed sale value is approximately $275,250.
  • The shares were acquired on 08/05/2026 via Restricted Stock Vesting from the issuer.
  • The filing states the sale is to cover a tax obligation from the settlement of a vested equity award distribution.
  • The sale is to be executed through Fidelity Brokerage Services LLC.

Financial Impact

Proposed sale of 2,240 shares valued at ~$275,250, representing a negligible fraction of the company's $8.2B market cap.

dilution

Risk Factors

  • Insider selling could increase if other directors or officers file additional Form 144s.
  • The stock's elevated valuation (94% analyst bullish consensus) introduces downside risk if fundamentals disappoint.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
94% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-005946
Document: 0001959173-26-005946-index.html0001959173-26-005946
Document: 0001959173-26-005946.txt0001959173-26-005946

Track record

47 reports on TWST

Performance horizon

8 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +55.24% at T+60 after the Aug 3, 2026 report. 10 of 12 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry $105.03 Now $111.60 +6.26% settles Dec 15
  2. Nov 16, 2026today 144 Neutral 2/10 Entry $105.16 Now $111.60 +6.12% settles Dec 15
  3. Nov 16, 2026today 144 Neutral 2/10 Entry $104.98 Now $111.60 +6.31% settles Dec 15
  4. Nov 16, 2026today 144 Neutral 2/10 Entry $105.61 Now $111.60 +5.67% settles Dec 15
  5. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $104.03 Now $111.60 +7.28% settles Dec 15
  6. Nov 12, 20264d ago 8-K Bullish 6/10 Entry $114.22 Now $111.60 −2.29% settles Dec 11
  7. Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $114.22 Now $111.60 −2.29% settles Dec 11
  8. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $132.13 Now $111.60 −15.54% settles Dec 9
  9. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $120.79 Now $111.60 −7.61% settles Dec 7
  10. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $120.61 Now $111.60 −7.47% settles Dec 4
Showing 10 of 47

US Market Status

Market Closed · Opens Wed (12h 48m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 12, 2026